Connection

Murray Passo to Rituximab

Back to Details
This is a "connection" page, showing publications Murray Passo has written about Rituximab.
Murray Passo
Connection Strength
0.136
Rituximab
  1. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America. Pediatr Rheumatol Online J. 2017 Jun 13; 15(1):50.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.